• 1. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 2. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 5. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Phenylpyrazoles

Introduction to 5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YLAMINE HYDROCHLORIDE (CAS No. 917950-33-5)

5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YLAMINE HYDROCHLORIDE, identified by the Chemical Abstracts Service Number (CAS No.) 917950-33-5, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This hydrochloride derivative of a pyrazoleamine exhibits unique structural and functional properties that make it a valuable candidate for further exploration in drug discovery and development. The compound's molecular structure, featuring a tert-butyl substituent and a phenyl ring, contributes to its distinct chemical behavior and potential biological activity.

The pyrazole core is a heterocyclic aromatic ring system that has garnered considerable attention in medicinal chemistry due to its versatility and prevalence in biologically active molecules. Pyrazole derivatives are known for their broad spectrum of pharmacological activities, including anti-inflammatory, antimicrobial, antiviral, and anticancer properties. The introduction of an amine group at the 3-position of the pyrazole ring further enhances its potential as a pharmacophore, enabling interactions with various biological targets.

The presence of a tert-butyl group at the 5-position of the pyrazole ring in 5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YLAMINE HYDROCHLORIDE serves multiple purposes. This bulky substituent can influence the compound's solubility, metabolic stability, and binding affinity to biological targets. The phenyl ring at the 2-position adds another layer of complexity, potentially enhancing the compound's interactions with enzymes or receptors through π-stacking interactions. These structural features make this compound an intriguing subject for computational modeling and experimental validation.

In recent years, there has been growing interest in developing novel small molecules that can modulate protein-protein interactions (PPIs) as a strategy for treating various diseases, including cancer and inflammatory disorders. Pyrazole derivatives have shown promise in this regard due to their ability to disrupt or stabilize PPIs. The amine group in 5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YLAMINE HYDROCHLORIDE provides a potential site for covalent or non-covalent binding to target proteins, making it a candidate for structure-based drug design.

One of the most exciting areas of research involving this compound is its potential application in oncology. Preclinical studies have demonstrated that certain pyrazole derivatives can inhibit the activity of kinases and other enzymes involved in cancer cell proliferation and survival. The specific combination of substituents in 5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YLAMINE HYDROCHLORIDE may confer selectivity against particular cancer-related pathways, offering a pathway to develop targeted therapies with improved efficacy and reduced side effects.

The hydrochloride salt form of this compound enhances its solubility in aqueous solutions, which is crucial for pharmaceutical formulations. Improved solubility can lead to better bioavailability and more effective drug delivery systems. This property makes 5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YLAMINE HYDROCHLORIDE particularly attractive for oral or injectable formulations, where dissolution rate plays a critical role in therapeutic outcomes.

Recent advancements in high-throughput screening (HTS) technologies have enabled researchers to rapidly evaluate large libraries of compounds for biological activity. This approach has been instrumental in identifying novel leads like 5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YLAMINE HYDROCHLORIDE. By leveraging HTS combined with computational techniques such as molecular docking and virtual screening, scientists can prioritize compounds based on their predicted binding affinity to target proteins.

The synthesis of this compound involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Key synthetic steps include the formation of the pyrazole ring followed by functionalization with the tert-butyl and phenyl groups. The introduction of the amine group at the 3-position is typically achieved through nucleophilic substitution or condensation reactions. Each step must be rigorously controlled to avoid unwanted byproducts that could compromise the compound's efficacy.

In conclusion, 5-TERT-BUTYL-2-PHENYL-2H-PYRAZOL-3-YLAMINE HYDROCHLORIDE (CAS No. 917950-33-5) represents a promising candidate for further investigation in pharmaceutical research. Its unique structural features, combined with its potential biological activities, make it an attractive molecule for drug discovery efforts aimed at treating cancer and other diseases. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in the development of next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)